| Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report |
151 |
| Risk and predictors of dementia and parkinsonism in idiopathic REM sleep behaviour disorder: a multicentre study |
102 |
| The cholinergic system in the pathophysiology and treatment of Alzheimer's disease |
93 |
| Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated |
77 |
| Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis |
70 |
| The compartmentalized inflammatory response in the multiple sclerosis brain is composed of tissue-resident CD8+T lymphocytes and B cells |
58 |
| Structural brain abnormalities in the common epilepsies assessed in a worldwide ENIGMA study |
55 |
| Longitudinal tau PET in ageing and Alzheimer's disease |
54 |
| The cerebellar cognitive affective/Schmahmann syndrome scale |
53 |
| Randomized trial of intermittent intraputamenal glial cell line-derived neurotrophic factor in Parkinson's disease |
49 |
| Phase 3 randomized, placebo-controlled, double-blind study of lasmiditan for acute treatment of migraine |
41 |
| The debated toxic role of aggregated TDP-43 in amyotrophic lateral sclerosis: a resolution in sight? |
39 |
| The landscape of the mesenchymal signature in brain tumours |
38 |
| Robust EEG-based cross-site and cross-protocol classification of states of consciousness |
38 |
| Incidence and phenotypes of childhood-onset genetic epilepsies: a prospective population-based national cohort |
36 |
| Progression of regional grey matter atrophy in multiple sclerosis |
36 |
| Cognition and dementia in older patients with epilepsy |
35 |
| Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines |
34 |
| Electrophysiological and transcriptomic correlates of neuropathic pain in human dorsal root ganglion neurons |
33 |
| JAK inhibitor improves type I interferon induced damage: proof of concept in dermatomyositis |
33 |
| The cerebellum in Alzheimer's disease: evaluating its role in cognitive decline |
33 |
| Nucleus basalis of Meynert degeneration precedes and predicts cognitive impairment in Parkinson's disease |
32 |
| Synaptic markers of cognitive decline in neurodegenerative diseases: a proteomic approach |
31 |
| Fibre-specific white matter reductions in Alzheimer's disease and mild cognitive impairment |
31 |
| LG antibodies alter K-v I.I and AMPA receptors changing synaptic excitability, plasticity and memory |
30 |
| Widespread brain tau and its association with ageing, Braak stage and Alzheimer's dementia |
30 |
| Neurological toxicities associated with chimeric antigen receptor T-cell therapy |
29 |
| Evolution of prodromal Parkinson's disease and dementia with Lewy bodies: a prospective study |
29 |
| Focused ultrasound thalamotomy location determines clinical benefits in patients with essential tremor |
29 |
| Microglial activation correlates in vivo with both tau and amyloid in Alzheimer's disease |
28 |
| Persistent neuropathological effects 14 years following amyloid-beta immunization in Alzheimer's disease |
28 |
| Is Parkinson's disease a lysosomal disorder? |
28 |
| A multicentre longitudinal study of flortaucipir (F-18) in normal ageing, mild cognitive impairment and Alzheimer's disease dementia |
28 |
| Functional connectivity associated with tau levels in ageing, Alzheimer's, and small vessel disease |
27 |
| White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer's disease |
26 |
| Plasma tau/amyloid-beta(1-42) ratio predicts brain tau deposition and neurodegeneration in Alzheimer's disease |
26 |
| Anatomy of aphasia revisited |
26 |
| Prevention of tau seeding and propagation by immunotherapy with a central tau epitope antibody |
26 |
| A fingerprint of the epileptogenic zone in human epilepsies |
26 |
| Tau burden and the functional connectome in Alzheimer's disease and progressive supranuclear palsy |
25 |
| Retiring the term FTDP-17 as MAPT mutations are genetic forms of sporadic frontotemporal tauopathies |
25 |
| Atlas of the normal intracranial electroencephalogram: neurophysiological awake activity in different cortical areas |
25 |
| Widespread FUS mislocalization is a molecular hallmark of amyotrophic lateral sclerosis |
25 |
| Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases |
25 |
| T helper 17.1 cells associate with multiple sclerosis disease activity: perspectives for early intervention |
25 |
| Handedness, language areas and neuropsychiatric diseases: insights from brain imaging and genetics |
25 |
| Hot-spot KIF5A mutations cause familial ALS |
25 |
| Predicting cognitive decline in multiple sclerosis: a 5-year follow-up study |
24 |
| Regional variation of Guillain-Barre syndrome |
24 |
| Interictal stereotactic-EEG functional connectivity in refractory focal epilepsies |
24 |
